Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 1,995.90
+52.55 (2.70%)
At close: Jan 22, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 563.61 billion as of January 23, 2026. Its market cap has increased by 22.08% in one year.
Market Cap
563.61B
Enterprise Value
548.95B
Revenue
159.97B
Ranking
n/a
PE Ratio
55.81
Stock Price
1,995.90
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 563.61B, an increase of 48,939.40%. That is a compound annual growth rate of 28.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 563.61B | -1.87% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.35T |
| Lupin | 977.28B |
| Dr. Reddy's Laboratories | 961.99B |
| Abbott India | 578.31B |
| GlaxoSmithKline Pharmaceuticals | 385.24B |
| J. B. Chemicals & Pharmaceuticals | 295.25B |
| AstraZeneca Pharma India | 206.24B |
| Jubilant Pharmova | 150.20B |